154 related articles for article (PubMed ID: 28494348)
21. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Narayanan NK; Nargi D; Randolph C; Narayanan BA
Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
[TBL] [Abstract][Full Text] [Related]
22. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
[TBL] [Abstract][Full Text] [Related]
23. Gata3 antagonizes cancer progression in Pten-deficient prostates.
Nguyen AH; Tremblay M; Haigh K; Koumakpayi IH; Paquet M; Pandolfi PP; Mes-Masson AM; Saad F; Haigh JJ; Bouchard M
Hum Mol Genet; 2013 Jun; 22(12):2400-10. PubMed ID: 23428429
[TBL] [Abstract][Full Text] [Related]
24. EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer.
Kim J; Kang HS; Lee YJ; Lee HJ; Yun J; Shin JH; Lee CW; Kwon BM; Hong SH
Cancer Lett; 2014 Jul; 349(1):35-44. PubMed ID: 24704156
[TBL] [Abstract][Full Text] [Related]
25. Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.
Amin H; Nayak D; Ur Rasool R; Chakraborty S; Kumar A; Yousuf K; Sharma PR; Ahmed Z; Sharma N; Magotra A; Mukherjee D; Kumar LD; Goswami A
Mol Carcinog; 2016 May; 55(5):864-81. PubMed ID: 25969134
[TBL] [Abstract][Full Text] [Related]
26. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO
Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879
[TBL] [Abstract][Full Text] [Related]
27. Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.
Anai S; Goodison S; Shiverick K; Iczkowski K; Tanaka M; Rosser CJ
Hum Gene Ther; 2006 Oct; 17(10):975-84. PubMed ID: 16984224
[TBL] [Abstract][Full Text] [Related]
28. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
[TBL] [Abstract][Full Text] [Related]
29. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
[TBL] [Abstract][Full Text] [Related]
30. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
[TBL] [Abstract][Full Text] [Related]
31. Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.
van Duijn PW; Marques RB; Ziel-van der Made ACJ; van Zoggel HJAA; Aghai A; Berrevoets C; Debets R; Jenster G; Trapman J; van Weerden WM
Prostate; 2018 Sep; 78(13):1013-1023. PubMed ID: 30133757
[TBL] [Abstract][Full Text] [Related]
32. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
[TBL] [Abstract][Full Text] [Related]
33. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
34. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
[TBL] [Abstract][Full Text] [Related]
35. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
36. Timp3 loss accelerates tumour invasion and increases prostate inflammation in a mouse model of prostate cancer.
Adissu HA; McKerlie C; Di Grappa M; Waterhouse P; Xu Q; Fang H; Khokha R; Wood GA
Prostate; 2015 Dec; 75(16):1831-43. PubMed ID: 26332574
[TBL] [Abstract][Full Text] [Related]
37. PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.
Rah B; ur Rasool R; Nayak D; Yousuf SK; Mukherjee D; Kumar LD; Goswami A
Autophagy; 2015; 11(2):314-31. PubMed ID: 25803782
[TBL] [Abstract][Full Text] [Related]
38. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
[TBL] [Abstract][Full Text] [Related]
39. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
[TBL] [Abstract][Full Text] [Related]
40. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]